To further investigate the immune-checkpoint blockade in iCCA, this study aims to use rat TAA-induced iCCA as an experimental model to analyze the immune response in iCCA using the immune-checkpoint DNA vaccine from the rat iCCA model. The gene discussed is PRRT2; the disease is infantile convulsions and choreoathetosis.